WO2026126235 - TREATMENT FOR RECURRENT PERICARDITIS
National phase entry is expected:
Publication Number
WO/2026/126235
Publication Date
18.06.2026
International Application No.
PCT/IN2025/052034
International Filing Date
10.12.2025
Title **
[English]
TREATMENT FOR RECURRENT PERICARDITIS
[French]
TRAITEMENT DE LA PÉRICARDITE RÉCURRENTE
Applicants **
ZYDUS LIFESCIENCES LIMITED
Inventors
JAIN, Mukul
CHATTERJEE, Abhijit
MOHAPATRA, Jogeswar
SHARMA, Manoranjan
KANSAGRA, Kevinkumar
PARMAR, Deven V.
Priority Data
202421097683
11.12.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2538 | |
| EPO | Filing, Examination, Granting | 18102 | |
| Japan | Filing, Examination, Granting | 2543 | |
| South Korea | Filing, Examination, Granting | 2914 | |
| USA | Filing, Examination, Granting | 9140 |
Total:
35,237
Contact Us
Abstract[English]
The present invention relates to the development of therapeutic compound of Formula (I) for the treatment of Recurrent Pericarditis. Specifically, the present invention provides a compound of Formula (I) or its pharmaceutically acceptable salt or suitable composition useful in the treatment of Recurrent Pericarditi s and other related disorders.[French]
La présente invention concerne le développement d'un composé thérapeutique de formule (I) pour le traitement de la péricardite récurrente. Plus précisément, la présente invention fournit un composé de formule (I) ou son sel pharmaceutiquement acceptable ou une composition appropriée utile dans le traitement de la péricardite récurrente et d'autres troubles associés.